Wednesday, February 10, 2010, 8:21am EST - Canadian Markets open in 1 hour and 9 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Integra LifeSciences Holdings Corporation (IART)

On Feb 9: 37.48 USD   0.00 (0.00%)  
MORE ON IART
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Integra LifeSciences Holdings C (NasdaqNM:IART) Delayed quote dataEdit
Last Trade: 37.48 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 37.48
Open: N/A
Bid: 0.01 x 200
Ask: 2,000.00 x 200
1y Target Est: 42.05
Day's Range: N/A - N/A
52wk Range: 18.97 - 40.50
Volume: 0
Avg Vol (3m): 145,808
Market Cap: 1.07B
P/E (ttm): 16.88
EPS (ttm): 2.22
Div & Yield: N/A (N/A%)
Integra LifeSciences Holdings Corporation (IART)
1d  5d  3m  6m  1y  2y  5y  max 
 Add IART to Portfolio   Download Data

HEADLINES
Award Winning Equity Analyst Sees 2010 Increase In Mergers And Acquisitions In Life Science Tools And Diagnostics Sector
Wall Street Transcript (Wed, Feb 3)
Coverage initiated on Integra by Barrington Research
Briefing.com (Mon, Jan 25)
Sector Snap: Orthopedic implant makers
AP (Wed, Jan 6)
Integra: JP Morgan Says "Buy," $46 Target
at Barrons.com (Mon, Jan 4)
New Contract for Integra
Zacks.com (Tue, Dec 22)
INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Dec 18)
INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Other Events
EDGAR Online (Mon, Nov 16)
INTEGRA LIFESCIENCES HOLDINGS CORP Financials
EDGAR Online Financials (Sat, Nov 7)
INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD D
EDGAR Online (Wed, Nov 4)
INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed, Nov 4)
INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Yea
EDGAR Online (Tue, Nov 3)
INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Other Events
EDGAR Online (Wed, Sep 9)
More Headlines for IART...

ANALYST
EPS Est (next year) (Dec-09) : 2.09
EPS Est (in 2 years) (Dec-10) : 2.33
Avg Rec (current)*: 2.1
PEG Ratio: 1.33
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, orthopedics, and general surgery in the United States and internationally.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices